Bank of America’s iShares Biotechnology ETF IBB Stock Holding History

Bank of America’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-50,000	Closed	-$6.39M	–	8520
2025 Q1	$6.39M	Buy	+50,000	New	+$6.78M	﹤0.01%	3574
2024 Q4	–	Sell	-123,300	Closed	-$18M	–	8291
2024 Q3	$18M	Sell	123,300 -272,300	-69%	-$39.4M	﹤0.01%	2504
2024 Q2	$54.3M	Buy	+395,600	New	+$52.8M	﹤0.01%	1390
2023 Q2	–	Sell	-600	Closed	-$77.5K	–	7811
2023 Q1	$77.5K	Sell	600 -900	-60%	-$118K	﹤0.01%	6349
2022 Q4	$197K	Sell	1,500 -152,000	-99%	-$19.6M	﹤0.01%	5921
2022 Q3	$18M	Buy	+153,500	New	+$19.1M	﹤0.01%	2070
2022 Q1	–	Sell	-73,500	Closed	-$11.2M	–	8478
2021 Q4	$11.2M	Buy	+73,500	New	+$11.4M	﹤0.01%	2805
2021 Q2	–	Sell	-734,000	Closed	-$111M	–	7878
2021 Q1	$111M	Buy	734,000 +674,100	+1,125%	+$107M	0.01%	835
2020 Q4	$9.07M	Buy	59,900 +34,000	+131%	+$4.86M	﹤0.01%	2568
2020 Q3	$3.51M	Buy	25,900 +300	+1%	+$40.7K	﹤0.01%	3240
2020 Q2	$3.5M	Buy	25,600 +25,400	+12,700%	+$3.24M	﹤0.01%	3171
2020 Q1	$22K	Sell	200 -97,200	-100%	-$11.2M	﹤0.01%	6152
2019 Q4	$11.7M	Sell	97,400 -6,100	-6%	-$681K	﹤0.01%	2398
2019 Q3	$10.3M	Sell	103,500 -107,200	-51%	-$11.2M	﹤0.01%	2487
2019 Q2	$23M	Buy	210,700 +141,300	+204%	+$15M	﹤0.01%	1749
2019 Q1	$7.76M	Buy	+69,400	New	+$7.61M	﹤0.01%	2730
2018 Q4	–	Sell	-30,500	Closed	-$3.72M	–	7216
2018 Q3	$3.72M	Buy	30,500 +30,200	+10,067%	+$3.56M	﹤0.01%	3470
2018 Q2	$33K	Sell	300 -93,400	-100%	-$9.99M	﹤0.01%	6328
2018 Q1	$10M	Buy	93,700 +63,700	+212%	+$7.06M	﹤0.01%	2414
2017 Q4	$3.2M	Sell	30,000 -506,400	-94%	-$54.1M	﹤0.01%	3536
2017 Q3	$59.6M	Buy	536,400 +461,400	+615%	+$49.3M	0.01%	1019
2017 Q2	$7.75M	Sell	75,000 -258,600	-78%	-$25.5M	﹤0.01%	2626
2017 Q1	$32.6M	Buy	333,600 +21,000	+7%	+$2.01M	0.01%	1336
2016 Q4	$27.7M	Sell	312,600 -859,800	-73%	-$78.3M	0.01%	1414
2016 Q3	$113M	Sell	1,172,400 -972,600	-45%	-$92.5M	0.02%	592
2016 Q2	$184M	Buy	2,145,000 +2,045,700	+2,060%	+$184M	0.04%	412
2016 Q1	$8.63M	Sell	99,300 -268,200	-73%	-$24M	﹤0.01%	2285
2015 Q4	$41.4M	Buy	367,500 +294,600	+404%	+$32M	0.01%	1120
2015 Q3	$7.37M	Buy	72,900 +44,400	+156%	+$5.33M	﹤0.01%	2497
2015 Q2	$3.5M	Sell	28,500 -46,500	-62%	-$5.57M	﹤0.01%	2920
2015 Q1	$8.59M	Sell	75,000 -24,600	-25%	-$2.71M	﹤0.01%	2006
2014 Q4	$10.1M	Buy	99,600 +91,800	+1,177%	+$8.92M	﹤0.01%	1927
2014 Q3	$711K	Buy	7,800 +5,700	+271%	+$500K	﹤0.01%	4285
2014 Q2	$180K	Sell	2,100 -53,700	-96%	-$4.23M	﹤0.01%	5647
2014 Q1	$4.4M	Sell	55,800 -44,100	-44%	-$3.67M	﹤0.01%	2515
2013 Q4	$7.56M	Buy	99,900 +90,900	+1,010%	+$6.45M	﹤0.01%	2103
2013 Q3	$629K	Sell	9,000 -1,800	-17%	-$118K	﹤0.01%	4417
2013 Q2	$626K	Buy	+10,800	New	+$624K	﹤0.01%	4529

Other funds holding IBB

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America's IBB Position: Q1 2026 in Review

Bank of America increased its iShares Biotechnology ETF (IBB) stake by 11% in Q1 2026, buying an estimated $121M and bringing the position to 7,259,501 shares worth $1.23B. The position accounts for 0.09% of the portfolio, ranked #215.

Bank of America first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.08B in Q4 2020. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Bank of America held 7,259,501 shares of iShares Biotechnology ETF worth $1.23B as of Q1 2026.
Bank of America bought 707,343 iShares Biotechnology ETF shares in Q1 2026, an estimated $121M.
iShares Biotechnology ETF made up 0.09% of Bank of America's portfolio in Q1 2026, its #215 holding.
Bank of America first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
Bank of America's iShares Biotechnology ETF position peaked at $2.08B in Q4 2020.
921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.